News
2d
Clinical Trials Arena on MSNOmRx Oncology begins Phase II trial of oral PD-L1 inhibitor for NSCLCClinical-stage biopharmaceutical venture OmRx Oncology (OmRx) has commenced a randomised Phase II clinical trial for its oral ...
How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function -- defective cell components are marked, disposed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results